Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
In the UK, new medicines must receive a marketing authorisation from the MHRA before they can be legally prescribed or dispensed
2017 Aug 8;17(1):96
Effectiveness In the main clinical study behind the pill (the 64-week OASIS 4 trial in adults with obesity or overweight), participants taking the 25 mg dose alongside diet and exercise lost on average around 14% of their starting body weight, compared with roughly 2.4% for those on a placebo
The focus is shifting towards comprehensive health benefits, including heart and kidney protection
Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes
US$ 25.82
US$ 27.25
US$ 25.06
